Immunotherapy of melanoma: current status and prospects for the future.

about

Adjuvant immunotherapy for patients with melanoma: are patients with melanoma of the head and neck candidates for this therapy?

P2860

Q41607151-89427AB7-E8D4-4811-9A57-A2C4200A729F

P2860

Immunotherapy of melanoma: current status and prospects for the future.

Item

http://www.wikidata.org/entity/Q40899717

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年学术文章

@wuu

1993年学术文章

@zh-cn

1993年学术文章

@zh-hans

1993年学术文章

@zh-my

1993年学术文章

@zh-sg

1993年學術文章

@yue

1993年學術文章

@zh

1993年學術文章

@zh-hant

name

Immunotherapy of melanoma: current status and prospects for the future.

@en

type

Item

label

Immunotherapy of melanoma: current status and prospects for the future.

@en

prefLabel

Immunotherapy of melanoma: current status and prospects for the future.

@en

P1476

Immunotherapy of melanoma: current status and prospects for the future.

@en

P2093

DeNunzio FD

http://www.w3.org/2001/XMLSchema#string

Irie RF

http://www.w3.org/2001/XMLSchema#string

P2860

Intralesional injection of the methanol extraction residue of Bacillus Calmette-Guerin (MER) into cutaneous metastases of malignant melanoma.

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction.

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.

Selective in vitro growth of T lymphocytes from normal human bone marrows.

Structure and expression of a cloned cDNA for human interleukin-2.

Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.

Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene.

Use of I-131 labeled, murine Fab against a high molecular weight antigen of human melanoma: preliminary experience.

P304

65-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1346-8138.1993.TB03833.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1993-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8478488

http://www.w3.org/2001/XMLSchema#string

Immunotherapy of melanoma: current status and prospects for the future.

about

P2860

P2860

Immunotherapy of melanoma: current status and prospects for the future.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698